erdosteine has been researched along with Acute Symptom Flare in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Calzetta, L; Cazzola, M; Matera, MG; Page, C; Rogliani, P | 1 |
Adir, Y; Avdeev, S; Calverley, PMA; Cordeiro, CR; Jesenak, M; Koblížek, V; Papi, A; Petkova, D; Rogliani, P; Tarraf, H; Tzanakis, N; Ulmeanu, R; Uzaslan, E | 1 |
Calverley, PMA; Cicero, AF; Dal Negro, RW; Fontana, G; Iversen, M; Page, C; Pozzi, E; Wedzicha, JA | 1 |
1 review(s) available for erdosteine and Acute Symptom Flare
Article | Year |
---|---|
Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Antioxidants; Drug Therapy, Combination; Expectorants; Humans; Lung; Oxidative Stress; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Symptom Flare Up; Thioglycolates; Thiophenes; Treatment Outcome | 2020 |
1 trial(s) available for erdosteine and Acute Symptom Flare
Article | Year |
---|---|
Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study.
Topics: Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Expectorants; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life; Severity of Illness Index; Symptom Flare Up; Thioglycolates; Thiophenes; Treatment Outcome | 2017 |
1 other study(ies) available for erdosteine and Acute Symptom Flare
Article | Year |
---|---|
Use of mucolytics in COPD: A Delphi consensus study.
Topics: Acetylcysteine; Carbocysteine; Consensus; Drug Therapy, Combination; Expectorants; Female; Health Status; Humans; Internationality; Male; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Surveys and Questionnaires; Symptom Flare Up; Thioglycolates; Thiophenes; Treatment Outcome | 2020 |